Transcatheter aortic valve implantation (TAVI) is a well-established treatment intervention in patients with symptomatic severe aortic stenosis. [1] Recent clinical trials have expanded the indication from high-risk patients by showing non-inferiority, as compared with surgical aortic valve replacement (SAVR). [2] However, the balance between improvements in long-term outcomes and risk of intervention-related permanent pacemaker implantation (PPI), in patients undergoing TAVI, is difficult. [3] A systematic review and meta analyses conducted on 43 TAVI studies identified age as a predictor of PPI within one-year after TAVI (odds ratio 1.05), [4] yet whether this association was procedure-related remains unclear. Such knowledge is warranted in the clinical decision making - both in elderly cases where life-expectancy is short and in younger cases, where SAVR may be considered. Thus, we set out to examine the one-year rates of PPI after TAVI according to age.